Fab'entech

Fab'entech, founded in 2009 and located in Lyon, France, is a member of the LyonBiopôle cluster. It is a biopharmaceutical company that develops and commercializes a series of innovative passive immunotherapy solutions based on specific polyclonal immunoglobulins [F(ab')2] for emerging infectious diseases and certain drug intoxications.